Patent · US Active

Stabilized formulations of CNS compounds

US8748472B2 · kind B2 · utility

6Cited by

2References

44Claims

0Family size

Assignee

Supernus Pharmaceuticals, Inc. · US

Inventors

Rong-Kun Chang · Rockville, US
Michael L. Vieira · Gaithersburg, US
Likan Liang · Wheeling, US
Padmanabh P. Bhatt · Rockville, US
Austin B. Huang · Potomac, US
Sachin V. Patel · Round Lake, US

Key dates

Filing date	Mar 30, 2011
Grant date	Jun 10, 2014
Priority date	—
Expiry date	Jul 25, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/1635
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Formulations of molindone having superior stability and methods of administering same are provided. The formulations may be immediate, modified, or otherwise delayed release formulations of molindone.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.